| The PRISMA 2020 statement: an updated guideline for reporting systematic reviews | BMJ, The | 2021 | 4.5K |
| PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews | BMJ, The | 2021 | 666 |
| The PRISMA 2020 statement: an updated guideline for reporting systematic reviews | Systematic Reviews | 2021 | 513 |
| The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | International Journal of Surgery | 2021 | 461 |
| The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | PLoS Medicine | 2021 | 286 |
| The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | Journal of Clinical Epidemiology | 2021 | 201 |
| Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study | BMJ, The | 2021 | 144 |
| Drug-eluting stents versus bare-metal stents for non-acute ischaemic heart disease | The Cochrane Library | 2021 | 78 |
| BCPT policy for experimental and clinical studies | Basic and Clinical Pharmacology and Toxicology | 2021 | 64 |
| Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study | Lancet Infectious Diseases, The | 2021 | 58 |
| Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial | Lancet, The | 2021 | 47 |
| Single cell transcriptional and chromatin accessibility profiling redefine cellular heterogeneity in the adult human kidney | Nature Communications | 2021 | 44 |
| Interleukin-6 blocking agents for treating COVID-19: a living systematic review | The Cochrane Library | 2021 | 43 |
| Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response | Immunity | 2021 | 41 |
| Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer | Cancer Cell | 2021 | 41 |
| Peripheral Nervous System Manifestations Associated with COVID-19 | Current Neurology and Neuroscience Reports | 2021 | 38 |
| Machine learning-based prognostic modeling using clinical data and quantitative radiomic features from chest CT images in COVID-19 patients | Computers in Biology and Medicine | 2021 | 37 |
| Myelin-oligodendrocyte glycoprotein antibody-associated disease | Lancet Neurology, The | 2021 | 37 |
| Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a prespecified substudy of a double-blind, randomised, placebo-controlled trial | Lancet Diabetes and Endocrinology,the | 2021 | 35 |
| The promise of artificial intelligence and deep learning in PET and SPECT imaging | Physica Medica | 2021 | 34 |
| Perspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: A Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe) | Cancer Medicine | 2021 | 31 |
| An overview of the effect of telehealth on mortality: A systematic review of meta-analyses | Journal of Telemedicine and Telecare | 2021 | 30 |
| Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement | JAMA - Journal of the American Medical Association | 2021 | 30 |
| Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases | RMD Open | 2021 | 28 |
| Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential | Acta Neuropathologica | 2021 | 24 |
